| ≥1 piece |
1.Initial volume expansion is 100%
2.MW 200kDa,Molar substitution0.5
3.Factory direct, competitive price
4.GMP certificate
1.Hydroxyethyl starch 200/0.5 as a raw material for the production of medicines on behalf of blood supplies is representing the highest level of the current plasma substitutes.
2..Our products are factory direct, long-term price advantage varieties, secure sources of raw materials and Long-term stable cooperation.
3.Advantages of our products as follows: 100% of the initial volume effect and 4-6-hour plateau effect; good security; the beneficial effects on blood rheology (micro cycle); minimal impact on blood coagulation; no plasma accumulation, significantly reduced tissue accumulation; the security of a large dose(50 ml / kg); no effect on renal function; better improvement in oxygen delivery; children aged 0-2 is safe to use.
4.Molecular weight is absolute and accurate data. Our company uses TAL method to measure endotoxin, high sensitivity, good security.Therefore, our product Hydroxyethyl Starch 130/0.4 is the first choice in the treatment of colloid volum.
| CAS No.: |
9005-27-0
|
Other Names: |
Hydroxyethyl starch
|
MF: |
(C6H10O5)m(C2H5O)n
|
| Place of Origin: |
Sichuan China (Mainland)
|
Type: |
Blood System Agents
|
Grade Standard: |
Medicine Grade
|
| Model Number: |
HES 130/0.4
|
Purity: |
>99%
|
Intrinsic viscosity: |
13.0-17.0
|
| Molar substitution: |
0.5
|
Molecular Weight: |
200k Da
|
color: |
white
|